Ashok K. Tuteja
No Rating Available
(Learn About Our Rating System)

Ashok K. Tuteja, MD, MRCP(UK), MPH

Languages spoken: English, Hindi, Panjabi

Clinical Locations

Redwood Health Center

Gastroenterology
Salt Lake City
801-213-9797

Veterans Administration Medical Center

Salt Lake City
801-584-1236

  • Ashok K. Tuteja, M.D., M.P.H., M.R.C.P. received his medical degree from Delhi University. He did his internal medicine residency in England where he was awarded Membership in the Royal College of Physicians (M.R.C.P.). He received his Masters in Public Health from Oregon Health Sciences University. He completed his gastroenterology fellowship at the University of Colorado.
     His clinical interests include irritable bowel syndrome, diarrhea, constipation, fecal incontinence, anal disorders, probiotics, biofeedback and colonoscopy. He has a special interest in bowel disorders in people who travel abroad. Dr. Tuteja’s main area of research is in the role of a change in intestinal bacteria during deployment or travel in causing a chronic change in bowel habits. He has numerous publications in peer-reviewed journals and referees scientific publications for several medical journals.

    Specialties

  • Ashok K. Tuteja, M.D., M.P.H., M.R.C.P. received his medical degree from Delhi University. He did his internal medicine residency in England where he was awarded Membership in the Royal College of Physicians (M.R.C.P.). He received his Masters in Public Health from Oregon Health Sciences University. He completed his gastroenterology fellowship at the University of Colorado.
     His clinical interests include irritable bowel syndrome, diarrhea, constipation, fecal incontinence, anal disorders, probiotics, biofeedback and colonoscopy. He has a special interest in bowel disorders in people who travel abroad. Dr. Tuteja’s main area of research is in the role of a change in intestinal bacteria during deployment or travel in causing a chronic change in bowel habits. He has numerous publications in peer-reviewed journals and referees scientific publications for several medical journals.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Gastroenterology

    Education history

    Graduate Training Epidemiology - Oregon Health Sciences Center M.P.H.
    Medicine - Delhi University M.D.
    Professional Medical Medicine - Delhi University M.B.B.S.

    Selected Publications

    Journal Article

    1. Mohan BP, Loganathan P, Khan SR, Garg G, Muthusamy A, Ponnada S, Pasam RT, Chandan S, Tuteja A (2023). Fecal microbiota transplant delivered via invasive routes in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials. Indian J Gastroenterol, 1-9. (Read full article)
    2. Tuteja AK, Talley NJ, Murtaugh MA, Loc-Carrillo CM, Stoddard GJ, Anderson GL (2022). Randomized, Double-Blind Placebo-Controlled Trial to Assess the Effect of Probiotics on Irritable Bowel Syndrome in Veterans With Gulf War Illness. Fed Pract, 39(10), 410-417. (Read full article)
    3. Tuteja AK, Talley NJ, Stoddard GJ, Verne GN (2018). Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome. Dig Dis Sci, 64(3), 838-845. (Read full article)
    4. Tuteja AK, Talley NJ, Stoddard GJ, Samore MH, Verne GN (2019). Risk factors for upper and lower functional gastrointestinal disorders in Persian Gulf War Veterans during and post-deployment. Neurogastroenterol Motil, 31(3), e13533. (Read full article)
    5. Tuteja AK, Fang JC, Al-Suqi M, Stoddard GJ, Hale DC (2012). Double-blind placebo-controlled study of mesalamine in post-infective irritable bowel syndrome--a pilot study. Scand J Gastroenterol, 47(10), 1159-64. (Read full article)
    6. Tuteja AK, Rao SS (2004). Review article: Recent trends in diagnosis and treatment of faecal incontinence. Aliment Pharmacol Ther, 19(8), 829-40. (Read full article)

    Review

    1. Goodoory VC, Tuteja AK, Black CJ, Ford AC (2023). Systematic Review and Meta-analysis: Efficacy of Mesalamine in Irritable Bowel Syndrome. [Review]. Clin Gastroenterol Hepatol. (Read full article)

    Letter

    1. Goodoory VC, Tuteja AK, Black CJ, Ford AC (2023). Reply. [Letter to the editor]. Clin Gastroenterol Hepatol. (Read full article)

    Abstract

    1. Tuteja AK, Tolman KG, Stoddard G, Gundupalli D, Talley N J, Verne GN (2014). (2014). Double-Blind Placebo Controlled Study of Rifaximin in Gulf War Veterans with Irritable Bowel Syndrome. (September), suppl. [Abstract]. Neurogastroenterology and Motility.
    2. Gundupalli D, Hatton-Ward S, Tuteja AK (2014). (2014).Anorectal Manometry in Constipation and Opioid-induced Constipation. (September), suppl. [Abstract]. Neurogastroenterology and Motility.